Does aging make older adults more vulnerable to rises in cystatin C and BUN before overt CKD is diagnosed?

Aging in humans is characterized by a steady attrition of renal anatomy and a corresponding decline in physiological buffer capacity, commonly referred to as renal functional reserve (RFR). For a 74-year-old individual, these changes often precede any clinical diagnosis of chronic kidney disease (CKD), rendering the kidneys more susceptible to biochemical shifts.

Structural and Mechanistic Changes

The aging kidney undergoes significant remodeling that directly reduces its functional ceiling.

• Nephron Attrition: Healthy individuals lose approximately 10,000 nephrons per kidney per year. By the eighth decade of life, the number of nonsclerotic glomeruli often drops from 1 million to roughly 520,000.
• Cellular Senescence: Podocyte depletion—cells that cannot regenerate—leads to focal glomerulosclerosis and interstitial fibrosis. These structural changes increase vascular resistance and impair the kidney’s ability to increase its filtration rate during physiological stress.
• Reduced RFR: While baseline glomerular filtration rate (GFR) may appear stable, the reduction in total nephron mass limits the RFR, which is the capacity to enhance GFR above baseline (e.g., during protein loading).

Biomarker Sensitivity in Aging

Traditional markers like serum creatinine often fail to detect early decline in older adults due to age-related sarcopenia (muscle loss), which reduces creatinine production.

• Cystatin C Superiority: Cystatin C is independent of muscle mass, making it a more sensitive indicator of early GFR impairment. Research indicates that using cystatin C-based equations reclassifies approximately 49% of older adults into lower, more impaired kidney function categories that creatinine-based tests miss.
• BUN and Subclinical Shifts: Elevations in blood urea nitrogen (BUN) and cystatin C frequently serve as "early warning" markers. These rises reflect subclinical tubulointerstitial changes and reduced filtration efficiency before the patient meets the formal diagnostic criteria for overt CKD.

Clinical Implications

Subclinical elevations in these markers are not benign. In older populations, rises in cystatin C and BUN are strongly associated with a higher risk of rapid kidney function decline, frailty, and all-cause mortality, even when creatinine levels remain within "normal" ranges.

Bottom line

Aging causes a profound loss of nephrons and structural resilience, making older adults highly vulnerable to rises in cystatin C and BUN. These markers often reveal subclinical renal impairment and a loss of functional reserve well before traditional diagnostics confirm chronic kidney disease.